Anesthesia Technician Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the Anesthesia Technician Exam. Prepare using flashcards and multiple choice questions, with hints and detailed explanations. Ace your test with confidence!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which of the following is NOT a step in treating Malignant Hyperthermia?

Administering dantrolene
Using cooling devices
Increasing the patient's heart rate
Providing medications as clinically indicated

The correct answer is: Increasing the patient's heart rate

Increasing the patient's heart rate is not a step in treating Malignant Hyperthermia. This condition is a life-threatening reaction to certain anesthesia agents, characterized by a rapid increase in body temperature and severe muscle contractions. The primary actions taken to manage Malignant Hyperthermia focus on reducing the elevated temperature and reversing the hypermetabolic state of the muscles. Administering dantrolene is a crucial step, as it acts to decrease calcium release from the sarcoplasmic reticulum of skeletal muscle, thereby alleviating the hypermetabolic crisis. Utilizing cooling devices is also essential in managing high body temperatures that can reach dangerous levels during an episode. Providing medications as clinically indicated includes other supportive treatments that may enhance patient stability. Therefore, while increasing heart rate can be a natural physiological response to stress, it is not a therapeutic goal in the management of Malignant Hyperthermia, where the emphasis is instead on controlling the hypermetabolic state and protecting the patient from further complications.